In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. After the evaluation of the results obtained from gene therapy and stem cells, in this part we evaluate micro-RNA, post-translational modification and microspheres based therapy.

[Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II] / Salzano, Andrea; Sirico, Domenico; Arcopinto, Michele; Marra, ALBERTO MARIA; Guerra, Germano; Rocca, Aldo; Grieco, Alessandra; Giallauria, Francesco; Vigorito, Carlo. - 82:4(2014), p. 195-201. [10.4081/monaldi.2014.64]

[Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II]

MARRA, ALBERTO MARIA;
2014

Abstract

In recent years, the remarkable progress achieved in terms of survival after myocardial infarction have led to an increased incidence of chronic heart failure in survivors. This phenomenon is due to the still incomplete knowledge we possess about the complex pathophysiological mechanisms that regulate the response of cardiac tissue to ischemic injury. These involve various cell types such as fibroblasts, cells of the immune system, endothelial cells, cardiomyocytes and stem cells, as well as a myriad of mediators belonging to the system of cytokines and not only. In parallel with the latest findings on post-infarct remodeling, new potential therapeutic targets are arising to halt the progression of disease. After the evaluation of the results obtained from gene therapy and stem cells, in this part we evaluate micro-RNA, post-translational modification and microspheres based therapy.
2014
Genetic Therapy; HMGB1 Protein; Humans; Microspheres; Outcome Assessment (Health Care); RNA Processing, Post-Transcriptional; Stem Cell Transplantation; Ventricular Remodeling; Heart Failure; MicroRNAs; Myocardial Infarction
01 Pubblicazione su rivista::01a Articolo in rivista
[Anti remodeling therapy: new strategies and future perspective in post-ischemic heart failure. Part II] / Salzano, Andrea; Sirico, Domenico; Arcopinto, Michele; Marra, ALBERTO MARIA; Guerra, Germano; Rocca, Aldo; Grieco, Alessandra; Giallauria, Francesco; Vigorito, Carlo. - 82:4(2014), p. 195-201. [10.4081/monaldi.2014.64]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/965003
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 7
  • ???jsp.display-item.citation.isi??? ND
social impact